Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

Boehringer Ingelheim Vetmedica Inc: Metacam (meloxicam) Oral Suspension Recalled for Potency Issues

Agency Publication Date: November 4, 2005
Share:
Sign in to monitor this recall

Summary

Boehringer Ingelheim Vetmedica Inc. is recalling approximately 2.28 million bottles of Metacam (meloxicam) 1.5 mg/mL Oral Suspension, a non-steroidal anti-inflammatory drug used for dogs. The recall was initiated because some units may have drug concentrations above or below specifications, which can affect the medication's effectiveness or safety. Approximately 631,560 bottles were distributed in the United States, with the remainder shipped to various international locations including Canada, the United Kingdom, and Australia.

Risk

Units that are below specification may not provide the intended pain relief or anti-inflammatory effect for the animal, while units above specification could lead to an accidental overdose of meloxicam, potentially causing adverse health effects in dogs.

What You Should Do

  1. Identify the affected product by checking the label for Metacam (meloxicam) 1.5 mg/mL Oral Suspension in 10-ml bottles (NDC 00010-6015-1).
  2. Check the bottle label for Lot Numbers 0157M17 or 0357M23. These lots may be labeled as manufactured by Boehringer Ingelheim Vetmedica, Inc. and distributed by Merial Limited, or labeled solely by Boehringer Ingelheim.
  3. If your product matches the affected lot numbers, contact your veterinarian or pharmacist immediately for guidance on whether to continue treatment or switch to a new bottle.
  4. Return any unused or remaining product from the affected lots to the pharmacy or veterinary clinic where it was purchased for a refund and further instructions.
  5. Contact the manufacturer, Boehringer Ingelheim Vetmedica Inc., at their Saint Joseph, Missouri location for additional information regarding this recall.
  6. For further questions or to report adverse events, contact the FDA Center for Veterinary Medicine at 1-888-FDA-VETS.

Your Remedy Options

💰Full Refund

Veterinary drug refund and professional consultation

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Metacam (meloxicam) 1.5 mg/mL Oral Suspension (10-ml bottle)
Model:
NADA #141-213
NDC 00010-6015-1
V-005-6
Lot Numbers:
0157M17
0357M23

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 33299
Status: Resolved
Manufacturer: Boehringer Ingelheim Vetmedica Inc
Sold By: Merial Limited; veterinary accounts
Manufactured In: United States
Units Affected: 2,287,326 bottles (631,560 bottles in the U.S., 1,655,766 foreign)
Distributed To: Iowa, Georgia, Tennessee

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response